Hematopoietic Stem Cell Biology And Leukemogenesis

Alessandra Giorgetti

PRINCIPAL INVESTIGATORS
  • Alessandra Giorgetti
POSTDOCTORAL RESEARCHERS
  • Oskar Marín Bejar
PREDOCTORAL RESEARCHERS
  • Alejandro Alonso Peinado
  • Joan Pera Garcia
SCIENTIFIC SUPPORT
  • Damià Romero Moya
Regenerative Medicine
Regenerative Medicine

Scientific production

2

PAPERS

Impact factor: 8,288

1 PUBLICATION IN FIRST DECILE

1 PUBLICATION IN FIRST QUARTILE

2 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Castaño J, Romero Moya D, Richaud Patin Y, Giorgetti A. Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency. Stem Cell Res. 2021;55102445-102445. doi:10.1016/j.scr.2021.102445. IF:2,02.
  • Maroni G, Bassal MA, Krishnan I, Fhu CW, Savova V, Zilionis R, Maymi VA, Pandell N, Csizmadia E, Zhang JY, Storti B, Castano J, Panella R, Li J, Gustafson CE, Fox S, Levy RD, Meyerovitz CV, Tramontozzi PJ, Vermilya K, De Rienzo A, Crucitta S, Basseres DS, Weetall M, Branstrom A, Giorgetti A, Ciampi R, Del Re M, Danesi R, Bizzarri R, Yang H, Kocher O, Klein AM, Welner RS, Bueno R, Magli MC, Clohessy JG, Ali A, Tenen DG, Levantini E. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer. Commun Biol. 2021;4(1):370-370. doi:10.1038/s42003-021-01897-6. IF:6,27.

Research highlights

PROJECTS

5 Competitive projects
1 Non-Competitive project

Selected projects

  • 21CEE006. Single cell tracking of malignant transformation in GATA2 deficiency. Marie Skłodowska-Curie Actions (MSCA) Individual Fellowships (IF), 2021-2024.IP: GIORGETTI, ALESSANDRA
  • 21MAR001. New approaches for the identification and functional characterization of prognostic genetic biomarkers in inherited childhood myelodysplastic/acute leukemia syndromes. Fundació la Marató de TV3 Rare Disease, Marató TV3 228/C/2021-2024
    IP: GIORGETTI, ALESSANDRA
  • MCI21006. Estudio de la transformación leucémica de la deficiencia de GATA2 mediante técnicas omicasâs en modelos de células madre humanas. (Track-GATA2-Leu). (PID2020-115591RB-I00). MINISTERIO DE CIENCIA E INNOVACIÓN (MICINN). 2021-2024. IP:  IORGETTI, ALESSANDRA.
  • 20DPS001. Human disease modelling of GATA2-related Myelodysplastic Syndromes and Acute Myeloid Leukemia. (SLT011/18/00006). DIR.GEN.SALUT PUBLICA, DEP.SALUT GE; FUNDACIO IDIBELL; FUNDACIÓ IMIM; SEMMELWEIS EGYETEM UNIVERSITY; UNIVERSITÄTSKLINIKUM FREIBURG. 2019-2022. IP:GIORGETTI, ALESSANDRA.
  • 20NOF001. Hematopoiesis and Blood Disorders (HBD). (2017SGR01077). AGENCIA GESTIO D’AJUTS UNIV. I RECERCA. 2018-2021. IP:GIORGETTI, ALESSANDRA.